published on 11/10/2023 at 08:00 from Arix Bioscience PLC (isin : GB00BD045071)

PDMR Notification & Director Shareholding

Arix Bioscience PLC (ARIX)
PDMR Notification & Director Shareholding

10-Nov-2023 / 07:00 GMT/BST

Arix Bioscience plc
("Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that Andrew Smith, Non-Executive Director of the Company purchased 25,000 Ordinary shares of 0.001 pence each in the Company (“Shares”) on 9th November 2023 at a price of £1.13 per share.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Andrew Smith
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Arix Bioscience plc Ordinary shares of 0.001 pence each
	Identification code	GB00BD045071
b)	Nature of the transaction	Share purchase
c)	Price(s) and volume(s)		Price(s)£	Volume(s)
			1.13	25,000
d)	Aggregated information
	- Aggregated volume	25,000
	- Price	£28,174.25
e)	Date of the transaction	9 November 2023
f)	Place of the transaction	London Stock Exchange

For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486

Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


ISIN:	GB00BD045071
Category Code:	DSH
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:	283953
EQS News ID:	1770099


End of Announcement	EQS News Service

See all Arix Bioscience PLC news